Immune Checkpoint Therapy–Induced Lupus Nephritis

Immune Checkpoint Therapy–Induced Lupus Nephritis

Saved in:

Bibliographic Details
Main Authors:	Imran Humza Hanif, Saifudeen Abdelrahim, Majd Al Shaarani, Huifang Lu, Raisa Ahmad, Sangeeta Goswami, Ala Abudayyeh
Format:	Article
Language:	English
Published:	Elsevier 2024-05-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924014852
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Urine proteomics defines an immune checkpoint-associated nephritis signature
by: Cassian Yee, et al.
Published: (2025-01-01)

Immune imbalance in Lupus Nephritis: The intersection of T-Cell and ferroptosis
by: Yunhe Fan, et al.
Published: (2024-12-01)

Urinary Immune Complexes Reflect Renal Pathology in Lupus Nephritis
by: Chenling Tang, et al.
Published: (2024-12-01)

The Involvement of MicroRNAs in Modulation of Innate and Adaptive Immunity in Systemic Lupus Erythematosus and Lupus Nephritis
by: Mohsen Honarpisheh, et al.
Published: (2018-01-01)

The Evolution of Crescents in Lupus Nephritis
by: Ana Malvar, et al.
Published: (2025-05-01)

Immune characterization of lupus nephritis patients undergoing dialysisKey messages
by: Quentin Simon, et al.
Published: (2025-06-01)

WCN24-1455 NOT EVERYTHING IN LUPUS IS LUPUS NEPHRITIS
by: Enrique Fleuvier Morales López, et al.
Published: (2024-04-01)

Gender Differences in the Pathogenesis and Outcome of Lupus and of Lupus Nephritis
by: Julie Schwartzman-Morris, et al.
Published: (2012-01-01)

Effects of renal replacement therapy combined with immune adsorption on inflammatory factors and immune function in patients with lupus nephritis
by: GAO Yang, et al.
Published: (2017-01-01)

Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis
by: Božić-Majstorović Ljubinka, et al.
Published: (2024-01-01)

Podocyte extracellular vesicles and immune mediators as urinary biomarkers in active lupus nephritis
by: Lilian Alves, et al.
Published: (2025-08-01)

Comprehensive analysis of IRF8-related genes and immune characteristics in lupus nephritis
by: Zhibin Yu, et al.
Published: (2024-12-01)

Measuring plasma C4D to monitor immune complexes in lupus nephritis
by: Tineke Kraaij, et al.
Published: (2019-12-01)

Prospects for the use of belimumab in lupus nephritis
by: N. L. Kozlovskaya, et al.
Published: (2021-08-01)

Evaluation of Treatment Response in Lupus Nephritis
by: Anca BOBIRCA, et al.
Published: (2021-12-01)

Recent advances in the treatment of lupus nephritis
by: Wan-xing Li, et al.
Published: (2022-08-01)

USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01)

Clinical application of belimumab in lupus nephritis
by: Zhou Han, et al.
Published: (2022-10-01)

The impacts of gender differences on systemic lupus erythematosus and lupus nephritis
by: LI Chun-hong, et al.
Published: (2019-01-01)

Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy
by: Yu Yamamoto, et al.
Published: (2022-03-01)

Lupus nephritis – modern aspects of diagnosis and therapy. Part I
by: S. K. Solovyev, et al.
Published: (2024-03-01)

Lupus nephritis. Part II, modern ideas about therapy
by: Elena A. Aseeva, et al.
Published: (2024-09-01)

WCN25-116 IT'S RARE BUT THERE: SEVER ANGIOEDEMA FOLLOWING RITUXIMAB TREATMENT FOR SEVER LUPUS NEPHRITIS
by: nihal bashir, et al.
Published: (2025-02-01)

Lupus nephritis: What new is in morphological diagnosis?
by: S G Radenska-Lopovok
Published: (2008-08-01)

Lupus Nephritis: 10 questions to think about
by: Enrique Morales, et al.
Published: (2025-02-01)

Chemokines and Chemokine Receptors in the Development of Lupus Nephritis
by: Xiaofeng Liao, et al.
Published: (2016-01-01)

Lupus nephritis and thrombotic microangiopathy: A review
by: Larisa A. Bobrova, et al.
Published: (2024-01-01)

Prediction of prognosis and renal outcome in lupus nephritis
by: Farah Tamirou, et al.
Published: (2020-10-01)

Disseminated Strongyloidiasis in a Patient With Lupus Nephritis
by: Muhammad Abu-Rmaileh, et al.
Published: (2023-09-01)

MicroRNAs Implicated in the Immunopathogenesis of Lupus Nephritis
by: Cristen B. Chafin, et al.
Published: (2013-01-01)

Renal biopsy in lupus nephritis: To do or not to do?
by: Manish Rathi, et al.
Published: (2017-01-01)

Clinical significance of urine hepcidin in lupus nephritis
by: TANG Dai-rong, et al.
Published: (2017-01-01)

B cells and treatment progression in lupus nephritis
by: ZHANG Yue-qi, et al.
Published: (2019-01-01)

Research advances of the role of T lymphocytes in lupus nephritis
by: Zhang Ling-ge, et al.
Published: (2022-03-01)

Ras-MAPK pathway in patients with lupus nephritis
by: Dandan Liang, et al.
Published: (2025-03-01)

Checkpoint inhibitor-related renal vasculitis and use of rituximab
by: Noha Abdel-Wahab, et al.
Published: (2020-10-01)

Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma
by: Raquibul Hannan, et al.
Published: (2020-10-01)

Lupus nephritis as a specific clinical and immunological phenotype of systemic lupus erythematosus
by: E. A. Aseeva, et al.
Published: (2022-12-01)

WCN25-2721 LUPUS NEPHRITIS IN PEDIATRICS: A CASE SERIES
by: AHMAD FARAZ, et al.
Published: (2025-02-01)

Overlap Syndrome in Late-Onset Systemic Lupus Erythematosus With Lupus Nephritis and MPO-ANCA Pauci-Immune Glomerulonephritis and Tuberculosis: An Uncommon Association
by: Jaime Arturo Dulce Muñoz, et al.
Published: (2025-01-01)